- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 519/00 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or
Patent holdings for IPC class C07D 519/00
Total number of patents in this class: 8842
10-year publication summary
|
529
|
524
|
616
|
632
|
657
|
755
|
813
|
964
|
1017
|
600
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4898 |
184 |
| Hoffmann-La Roche Inc. | 3418 |
172 |
| Gilead Sciences, Inc. | 2036 |
149 |
| Merck Sharp & Dohme LLC | 3748 |
148 |
| Incyte Corporation | 1024 |
143 |
| F. Hoffmann-La Roche AG | 7925 |
136 |
| Merck Patent GmbH | 5831 |
125 |
| Janssen Pharmaceutica N.V. | 3392 |
123 |
| Genentech, Inc. | 3976 |
113 |
| Boehringer Ingelheim International GmbH | 4650 |
106 |
| Takeda Pharmaceutical Company Limited | 2713 |
100 |
| Pfizer Inc. | 3387 |
97 |
| Amgen Inc. | 4074 |
80 |
| Novartis AG | 10849 |
76 |
| Array BioPharma Inc. | 502 |
70 |
| Idemitsu Kosan Co., Ltd. | 4219 |
64 |
| ImmunoGen, Inc. | 399 |
59 |
| Bayer AG | 3330 |
53 |
| Medshine Discovery Inc. | 600 |
52 |
| Samsung Display Co., Ltd. | 34696 |
51 |
| Other owners | 6741 |